ISSN:
1435-1463
Keywords:
Keywords: Ropinirole
;
pergolide
;
bromocriptine
;
Parkinson's disease.
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary. Patients with Parkinson's disease (n = 68) switched from per-golide or bromocriptine to ropinirole overnight (dose equivalence ratios – 1 : 6 and 10 : 6, respectively). The activities of daily living score for the Unified Parkinson's Disease Rating Scale (UPDRS) was significantly improved 4 weeks after the bromocriptine–ropinirole switch. All other UPDRS scores, including that for the side-effect component, were not significantly different after either switch. Overnight switching may be a safe therapeutic approach that may reduce hospitalisation and related socio-economic costs.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s007020050212
Permalink